Advertisement
Screener

Infinity Pharmaceuticals, Inc. Interest Expense, Related Party

Infinity Pharmaceuticals, Inc. Interest Expense, Related Party

Infinity Pharmaceuticals, Inc. reported Interest Expense, Related Party of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpenseRelatedParty · last filed 2022-03-29

  • Infinity Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
  • Infinity Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
  • Infinity Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
  • Infinity Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
  • Infinity Pharmaceuticals, Inc. interest expense, related party for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
  • Infinity Pharmaceuticals, Inc. interest expense, related party for fiscal 2020 was $2.29M.
  • Infinity Pharmaceuticals, Inc. interest expense, related party for fiscal 2019 was $0.00.
Period endInterest Expense, Related Party 3 monthInterest Expense, Related Party 6 monthInterest Expense, Related Party 9 monthInterest Expense, Related Party 12 month
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$0.00
derived: sum of 2 quarters · filed 2022-03-29
$0.00
derived: sum of 3 quarters · filed 2022-03-29
$0.00
10-K · filed 2022-03-29
2021-09-30$0.00
10-Q · filed 2021-11-02
$0.00
derived: sum of 2 quarters · filed 2021-11-02
$0.00
10-Q · filed 2021-11-02
$605.00K
derived: sum of 4 quarters · filed 2022-03-29
2021-06-30$0.00
10-Q · filed 2021-07-27
$0.00
10-Q · filed 2021-07-27
$605.00K
derived: sum of 3 quarters · filed 2022-03-29
$1.19M
derived: sum of 4 quarters · filed 2022-03-29
2021-03-31$0.00
10-Q · filed 2021-05-13
$605.00K
derived: sum of 2 quarters · filed 2022-03-29
$1.19M
derived: sum of 3 quarters · filed 2022-03-29
$1.76M
derived: sum of 4 quarters · filed 2022-03-29
2020-12-31$605.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$1.19M
derived: sum of 2 quarters · filed 2022-03-29
$1.76M
derived: sum of 3 quarters · filed 2022-03-29
$2.29M
10-K · filed 2022-03-29
2020-09-30$588.00K
10-Q · filed 2021-11-02
$1.15M
derived: sum of 2 quarters · filed 2021-11-02
$1.69M
10-Q · filed 2021-11-02
$1.69M
derived: sum of 4 quarters · filed 2021-11-02
2020-06-30$565.00K
10-Q · filed 2021-07-27
$1.10M
10-Q · filed 2021-07-27
$1.10M
derived: sum of 3 quarters · filed 2021-07-27
$1.10M
derived: sum of 4 quarters · filed 2021-07-27
2020-03-31$534.00K
10-Q · filed 2021-05-13
$534.00K
derived: sum of 2 quarters · filed 2021-05-13
$534.00K
derived: sum of 3 quarters · filed 2021-05-13
$534.00K
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
$0.00
derived: sum of 2 quarters · filed 2021-03-16
$0.00
derived: sum of 3 quarters · filed 2021-03-16
$0.00
10-K · filed 2021-03-16
2019-09-30$0.00
10-Q · filed 2020-11-09
$0.00
derived: sum of 2 quarters · filed 2020-11-09
$0.00
10-Q · filed 2020-11-09
2019-06-30$0.00
10-Q · filed 2020-07-30
$0.00
10-Q · filed 2020-07-30
2019-03-31$0.00
10-Q · filed 2020-05-11